2022 - TID 2022 Virtual
This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Day 2: Thursday, November 17
2.3 - Session 3 - Infection Risk with Emerging Stem Cell Transplant Treatments
Presenter: Anton Peleg, Steve Pergam, , ,
Authors: Anton Peleg, Steve Pergam, Jennifer Saullo, Jasmine Chung
Session 3 - Infection Risk with Emerging Stem Cell Transplant Treatments
Moderators: Jennifer Saullo, United States; and Jasmine Chung, Singapore
CAR-T Infections
Bio
The Alfred Hospital, Monash University
Anton Peleg is a Professor of Infectious Diseases and Microbiology, NHMRC Practitioner Fellow and Director of the Department of Infectious Diseases at The Alfred Hospital and Monash University, Melbourne, VIC. He is Theme Leader for Infection and Immunity at Monash Academic Health Research and Translational Centre, and has recently been elected as a Fellow of the Australian Academy of Health and Medical Sciences.
He completed his infectious diseases clinical training in Australia in 2005 and then went to the USA for four years and worked at the Harvard-affiliated hospitals; Beth Israel Deaconess Medical Center and Massachusetts General Hospital. He completed a Masters of Public Health at Harvard School of Public Health, and also completed a PhD in Infectious Diseases and Microbiology with a focus on antimicrobial resistance (AMR) and genomics. He returned to Australia in 2010 as a clinician-scientist.
His research interests are in hospital-acquired infections, AMR and novel solutions, bacterial genomics, mechanisms of pathogenesis and infections in immunocompromised hosts. He is also an active clinician working in the area of hospital-acquired infections and transplant infectious diseases. He has received numerous national and international awards for his advanced research and contribution to Infectious Diseases and Microbiology.
Bone Marrow Donation Safety
Bio
Fred Hutchinson Cancer Research Center
Dr. Steven Pergam is an Associate Member in the Clinical Research and Vaccine and Infectious Diseases Division of the Fred Hutchinson Cancer Research Center; Associate Professor in the Division of Allergy & Infectious Diseases at the University of Washington; and the Director of Infection Prevention at the Seattle Cancer Care Alliance, in Seattle, WA. His current research interest focuses on the epidemiology of major transplant pathogens and on the development of novel prevention strategies for community and healthcare-associated infections in cancer and hematopoietic cell transplant patients.
Important Disclaimer
By viewing the material on this site you understand and accept that:
- The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
- The material is solely for educational purposes for qualified health care professionals.
- The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
- The information cannot be used as a substitute for professional care.
- The information does not represent a standard of care.
- No physician-patient relationship is being established.
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada